Difference between revisions of "Medicines for children"

From Powerbase
Jump to: navigation, search
m
 
Line 1: Line 1:
An intergal practice of the European Commission's pharmaceutical unit is to ensure a good quality of medicinal products for paedriatic use.  In response to the incidence of inadequate medicines for children in Europe, the European Commission implemented a proposal on the 29th September 2004.  Additionally this legislation seeks to promote the development of paediatric medicines, whereby at the national scale of EU member states have a role to play in providing national incentives for the research and development of such pharmaceuticals. <ref> Regulation on medicines for children http://ec.europa.eu/enterprise/pharmaceuticals/paediatrics/docs/paeds_qa_october_28.pdf Accessed 1/03/08 </ref>
 
  
==Notes==
 
 
<references/>
 

Latest revision as of 15:37, 4 March 2008